InfuSystem Holdings Announces Expiration of Warrants
MADISON HEIGHTS, Mich., April 12, 2011 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading provider of infusion pumps and associated products and services in the U.S. and Canada has announced today that all 9,472,496 outstanding warrants to acquire shares of its common stock have expired in accordance with their terms on April 11, 2011 and are no longer outstanding. The warrants had been issued in connection with the Company's initial public offering of common stock units (and in certain private placements in the year after the initial public offering). As of April 12, 2011, the Company's capital structure consists of 21,056,133 shares of Common Stock issued and outstanding.
InfuSystem is a leading provider of ambulatory infusion pumps to the outpatient oncology market as well as new and pre-owned infusion pumps and other biomedical equipment, and biomedical recertification, maintenance and repair services to hospitals, oncology practices and other alternate site health care providers. Headquartered in Madison Heights, Michigan, InfuSystem delivers local, field-based customer support and operates Biomedical Service Centers of Excellence in Kansas City, Los Angeles and Toronto.
CONTACT: Investor Contact:
Pat LaVecchia
info@infusystem.com
Tel: (800) 962-9656
Media Contact:
David Haar
info@infusystem.com
Tel: (800) 962-9656
Source: InfuSystem, Inc.
Recent INFU News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 09:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 10:58:43 AM
- InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC • Business Wire • 09/11/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 10:31:28 AM
- InfuSystem to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024 • Business Wire • 09/04/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:35:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 10:31:11 AM
- InfuSystem Reports Second Quarter 2024 Financial Results • Business Wire • 08/08/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 10:30:28 AM
- InfuSystem Announces Distribution Agreement with Smith+Nephew for Negative Pressure Wound Therapy System and First Shipment of NPWT Systems • Business Wire • 08/06/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:30:26 PM
- InfuSystem to Report Second Quarter 2024 Financial Results on August 8, 2024 • Business Wire • 08/02/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:39:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:31:11 PM
- InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024 • Business Wire • 06/04/2024 08:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 11:02:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 10:22:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 10:19:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 10:17:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 10:14:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 10:12:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 10:09:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:23 PM
- InfuSystem Announces $20 Million Stock Repurchase Program • Business Wire • 05/20/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:53:06 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM